Department of Immunization, Vaccines, and Biologicals, World Health Organization, Geneva, Switzerland.
Department of Health Security Preparedness, World Health Organization, Geneva, Switzerland.
Front Public Health. 2024 May 14;12:1376113. doi: 10.3389/fpubh.2024.1376113. eCollection 2024.
To optimize the efficient introduction and deployment of COVID-19 vaccines across the globe during the COVID-19 pandemic, in April 2021 WHO launched a new process and tools for countries to rapidly review the early phase of countries' COVID-19 vaccine introduction. This methodology is called the COVID-19 vaccination intra-action review, also known as mini COVID-19 vaccine post-introduction evaluation (mini-cPIE). As of November 2022, 46 mini-cPIEs had been conducted. In collaboration with Project ECHO, WHO convened and facilitated real-time experience sharing and peer-learning among countries following their mini-cPIEs through a virtual global real-time learning forum. This five-session clinic series was attended by 736 participants from 129 countries. Based on post-session feedback surveys, when asked about the utility of the sessions, half of the participants said that sessions led them to review national guidelines and protocols or make other changes to their health systems. The post-series survey sent following the end of the clinic series showed that at least eight countries subsequently conducted a mini-cPIE after participating in the clinics, and participants from at least nine countries indicated the experience shared by peer countries on the clinic largely benefited their COVID-19 vaccine introduction and deployment. In this article, we highlight the benefits and importance of creating a global experience-sharing forum for countries to connect and share pertinent learnings in real-time during an international public health emergency. Moving forward, it is critical to foster a culture of individual and collective learning within and between countries during public health emergencies, with WHO playing an important convening role.
为了优化 COVID-19 大流行期间全球范围内 COVID-19 疫苗的高效引入和部署,世界卫生组织(WHO)于 2021 年 4 月推出了一个新流程和工具,供各国快速审查各国 COVID-19 疫苗引入的早期阶段。该方法称为 COVID-19 疫苗行动内审查,也称为迷你 COVID-19 疫苗引入后评估(mini-cPIE)。截至 2022 年 11 月,已进行了 46 次 mini-cPIE。与世卫组织 ECHO 项目合作,世卫组织通过一个虚拟的全球实时学习论坛,召集并促进各国在进行 mini-cPIE 后实时分享经验和开展同行学习。来自 129 个国家的 736 名参与者参加了这个为期五节的临床系列。根据会后反馈调查,当被问及这些会议的实用性时,一半的参与者表示,这些会议促使他们审查了国家指南和方案,或对其卫生系统进行了其他更改。在临床系列结束后发送的后续系列调查显示,至少有八个国家在参加了临床后进行了 mini-cPIE,至少有九个国家的参与者表示,同行国家在临床系列中分享的经验极大地促进了他们的 COVID-19 疫苗引入和部署。本文强调了在国际公共卫生紧急情况下为各国创建一个实时连接和共享相关经验的全球经验共享论坛的好处和重要性。展望未来,在世卫组织发挥重要召集作用的情况下,在公共卫生紧急情况下,各国必须培养个人和集体学习的文化,无论是在国内还是在国际层面。